These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Activation of phospholipase A2 and acylation of lysophospholipids: the major regulators for platelet activating factor production in rat neutrophils. Naraba H, Imai Y, Kudo I, Nakagawa Y, Oh-ishi S. J Biochem; 1995 Aug; 118(2):442-7. PubMed ID: 8543583 [Abstract] [Full Text] [Related]
10. Endothelial cell associated platelet-activating factor (PAF), a costimulatory intermediate in TNF-alpha-induced H2O2 release by adherent neutrophil leukocytes. von Asmuth EJ, Buurman WA. J Immunol; 1995 Feb 01; 154(3):1383-90. PubMed ID: 7529802 [Abstract] [Full Text] [Related]
11. Effect of immunological stimulation on the production of platelet-activating factor by rat peritoneal cells: its relevance to anaphylactic reactions. Pellon MI, Fernandez-Gallardo S, Gijon MA, Garcia MC, Liu FT, Sanchez Crespo M. Immunopharmacology; 1993 Feb 01; 26(1):73-82. PubMed ID: 8407286 [Abstract] [Full Text] [Related]
12. An anti-inflammatory protein secreted from the rat seminal vesicle epithelium inhibits the synthesis of platelet-activating factor and the release of arachidonic acid and prostacyclin. Camussi G, Tetta C, Bussolino F, Metafora S, Peluso G, Esposito C, Porta R. Eur J Biochem; 1990 Sep 11; 192(2):481-5. PubMed ID: 2209604 [Abstract] [Full Text] [Related]
14. Tumor necrosis factor stimulates human neutrophils to release leukotriene B4 and platelet-activating factor. Induction of phospholipase A2 and acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase activity and inhibition by antiproteinase. Camussi G, Tetta C, Bussolino F, Baglioni C. Eur J Biochem; 1989 Jul 01; 182(3):661-6. PubMed ID: 2546764 [Abstract] [Full Text] [Related]
15. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds. Hogaboam CM, Donigi-Gale D, Shoupe TS, Bissonnette EY, Befus AD, Wallace JL. Br J Pharmacol; 1992 Jan 01; 105(1):87-92. PubMed ID: 1596692 [Abstract] [Full Text] [Related]
16. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes. Jouvin-Marche E, Ninio E, Beaurain G, Tence M, Niaudet P, Benveniste J. J Immunol; 1984 Aug 01; 133(2):892-8. PubMed ID: 6736649 [Abstract] [Full Text] [Related]
17. Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. Camussi G, Tetta C, Bussolino F, Baglioni C. J Exp Med; 1990 Mar 01; 171(3):913-27. PubMed ID: 2137857 [Abstract] [Full Text] [Related]
18. Synthesis of platelet-activating factor by polymorphonuclear neutrophils stimulated with interleukin-8. Bussolino F, Sironi M, Bocchietto E, Mantovani A. J Biol Chem; 1992 Jul 25; 267(21):14598-603. PubMed ID: 1634507 [Abstract] [Full Text] [Related]
19. Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation. Ribaldi E, Mezzasoma AM, Francescangeli E, Prosdocimi M, Nenci GG, Goracci G, Gresele P. Br J Pharmacol; 1996 Jul 25; 118(6):1351-8. PubMed ID: 8832056 [Abstract] [Full Text] [Related]
20. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor. Breviario F, Bertocchi F, Dejana E, Bussolino F. J Immunol; 1988 Nov 15; 141(10):3391-7. PubMed ID: 3263425 [Abstract] [Full Text] [Related] Page: [Next] [New Search]